Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.
cardiac implantable electronic device
complications
implantable cardioverter- -defibrillator
pacemaker
Journal
Cardiology journal
ISSN: 1898-018X
Titre abrégé: Cardiol J
Pays: Poland
ID NLM: 101392712
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
10
2018
accepted:
31
03
2019
revised:
24
03
2019
pubmed:
22
6
2019
medline:
18
9
2021
entrez:
22
6
2019
Statut:
ppublish
Résumé
The frequency of cardiac implantable electronic device (CIED) implantations is constantly increasing. Pericardial effusion (PE) and tricuspid regurgitation (TR) may occur after CIED implantation. The aim of the present study is to evaluate the prevalence and risk factors for new occurrences or progression of TR and PE early after CIED implantation. This is an on-going, single-center, observational study of patients after their first CIED implantation, with an echocardiographic evaluation within 60 days before and 7 days after the procedure. Data are presented for first 110 consecutive patients who underwent CIED implantation from August 2015 to July 2016. Median age was 75 years, and 44% were women. In total, 87 (79%) pacemakers, 21 (19%) implantable cardioverter-defibrillators and 2 cardiac resynchronization therapy devices were implanted. After CIED implantation, there was TR progression in 17 (16%) patients: 5 patients developed moderate TR, none developed severe TR. An increase in TR was more often observed after implantations performed by operators in training than by certified operators (35% vs. 12%, p = 0.02). New PE after the procedure was observed in 8 (7%) patients and was trivial ( < 5 mm) in all cases. Patients with new PE after implantation had lower baseline hemoglobin levels and tended to be women. New PE and an increase in TR severity are rare complications early after CIED implantation. Operator experience might be related to TR progression. Increasing the number of patients in the current on-going study will allow a more reliable assessment of the prevalence and risk factors of these complications.
Sections du résumé
BACKGROUND
The frequency of cardiac implantable electronic device (CIED) implantations is constantly increasing. Pericardial effusion (PE) and tricuspid regurgitation (TR) may occur after CIED implantation. The aim of the present study is to evaluate the prevalence and risk factors for new occurrences or progression of TR and PE early after CIED implantation.
METHODS
This is an on-going, single-center, observational study of patients after their first CIED implantation, with an echocardiographic evaluation within 60 days before and 7 days after the procedure. Data are presented for first 110 consecutive patients who underwent CIED implantation from August 2015 to July 2016.
RESULTS
Median age was 75 years, and 44% were women. In total, 87 (79%) pacemakers, 21 (19%) implantable cardioverter-defibrillators and 2 cardiac resynchronization therapy devices were implanted. After CIED implantation, there was TR progression in 17 (16%) patients: 5 patients developed moderate TR, none developed severe TR. An increase in TR was more often observed after implantations performed by operators in training than by certified operators (35% vs. 12%, p = 0.02). New PE after the procedure was observed in 8 (7%) patients and was trivial ( < 5 mm) in all cases. Patients with new PE after implantation had lower baseline hemoglobin levels and tended to be women.
CONCLUSIONS
New PE and an increase in TR severity are rare complications early after CIED implantation. Operator experience might be related to TR progression. Increasing the number of patients in the current on-going study will allow a more reliable assessment of the prevalence and risk factors of these complications.
Identifiants
pubmed: 31225634
pii: VM/OJS/J/61466
doi: 10.5603/CJ.a2019.0053
pmc: PMC8079086
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
797-806Références
Clin Cardiol. 2013 May;36(5):249-54
pubmed: 23529935
Circ Cardiovasc Interv. 2009 Dec;2(6):565-73
pubmed: 20031775
Am J Cardiol. 1998 Nov 1;82(9):1130-2, A9
pubmed: 9817497
Cardiol J. 2018;25(4):423-440
pubmed: 30211927
Am J Cardiol. 1999 Mar 15;83(6):897-902
pubmed: 10190406
Pacing Clin Electrophysiol. 2002 Jul;25(7):1131-4
pubmed: 12164456
Pacing Clin Electrophysiol. 2002 Nov;25(11):1583-6
pubmed: 12494615
Heart. 2014 Jun;100(12):960-8
pubmed: 24449717
JAMA. 1974 Oct 7;230(1):86-7
pubmed: 4479257
Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S135-7
pubmed: 19250077
J Am Soc Echocardiogr. 2008 Mar;21(3):284-7
pubmed: 17604958
Circ J. 2013;77(4):975-81
pubmed: 23269085
J Am Coll Cardiol. 2004 Feb 4;43(3):405-9
pubmed: 15013122
Europace. 2013 Aug;15(8):1070-118
pubmed: 23801827
Del Med J. 2015 Aug;87(8):244-7
pubmed: 26402927
Cardiol J. 2015;22(6):637-44
pubmed: 26412607
Eur Heart J. 2015 Nov 7;36(42):2921-2964
pubmed: 26320112
Am J Med. 2017 Jun;130(6):720-730
pubmed: 28109968
Adv Med Sci. 2018 Mar;63(1):30-35
pubmed: 28818746
J Interv Card Electrophysiol. 2017 Sep;49(3):281-287
pubmed: 28685199
J Am Coll Cardiol. 2010 May 25;55(21):2376-82
pubmed: 20488310
J Am Coll Cardiol. 2005 May 17;45(10):1672-5
pubmed: 15893186
Pacing Clin Electrophysiol. 2015 Feb;38(2):259-66
pubmed: 25377489
J Interv Card Electrophysiol. 2008 Jan;21(1):65-8
pubmed: 18040765
Images Paediatr Cardiol. 2006 Apr;8(2):17-81
pubmed: 22368662
Angiology. 1995 May;46(5):421-4
pubmed: 7741326
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611-44
pubmed: 23733442
Ghana Med J. 2009 Jun;43(2):71-6
pubmed: 21326845
Europace. 2015 Jan;17 Suppl 1:i1-75
pubmed: 25616426